Novavax (NVAX) and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Va
Go back to Novavax (NVAX) and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Va| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 10.00 +0.65 (6.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.35 | 52 Week High | $9.23 | |||
| Open | $9.61 | 52 Week Low | $1.16 | |||
| Day High | $10.38 | P/E | N/A | |||
| Day Low | $9.61 | EPS | $-0.30 | |||
| Volume | 8,876,153 | |||||
